Pseudodiabetes—not a contraindication for metabolic interventions

José Manuel Bravo-San Pedro; Valentina Sica; Guido Kroemer

doi:10.1038/s41419-019-2007-1

Pseudodiabetes—not a contraindication for metabolic interventions

José Manuel Bravo-San Pedro, Valentina Sica, Guido Kroemer

Résultats de recherche: Contribution à un journal › !!Comment/debate

1 Citation (Scopus)

Résumé

Type-2 diabetes is characterized by glycosuria, hyperglycemia, glucose intolerance, hyperinsulinemia, and insulin resistance. One or several among these alterations are also found after starvation, ketogenic diet, and pharmacological treatment with rapamycin or antibody-mediated neutralization of the obesogenic factor ACBP/DBI. Thus, a variety of metabolic interventions that improve metabolic health can induce a transient state of “pseudo-diabetes”.

langue originale	Anglais
Numéro d'article	765
journal	Cell Death and Disease
Volume	10
Numéro de publication	10
Les DOIs	https://doi.org/10.1038/s41419-019-2007-1
état	Publié - 1 oct. 2019

Accès au document

10.1038/s41419-019-2007-1

Autres fichiers et liens

Lien vers la publication dans Scopus

Contient cette citation

@article{627ac4296eb64c548efe325e7b675385,

title = "Pseudodiabetes—not a contraindication for metabolic interventions",

abstract = "Type-2 diabetes is characterized by glycosuria, hyperglycemia, glucose intolerance, hyperinsulinemia, and insulin resistance. One or several among these alterations are also found after starvation, ketogenic diet, and pharmacological treatment with rapamycin or antibody-mediated neutralization of the obesogenic factor ACBP/DBI. Thus, a variety of metabolic interventions that improve metabolic health can induce a transient state of “pseudo-diabetes”.",

author = "{Bravo-San Pedro}, {Jos{\'e} Manuel} and Valentina Sica and Guido Kroemer",

note = "Publisher Copyright: {\textcopyright} 2019, The Author(s).",

year = "2019",

month = oct,

day = "1",

doi = "10.1038/s41419-019-2007-1",

language = "English",

volume = "10",

journal = "Cell Death and Disease",

issn = "2041-4889",

number = "10",

}

TY - JOUR

T1 - Pseudodiabetes—not a contraindication for metabolic interventions

AU - Bravo-San Pedro, José Manuel

AU - Sica, Valentina

AU - Kroemer, Guido

PY - 2019/10/1

Y1 - 2019/10/1

N2 - Type-2 diabetes is characterized by glycosuria, hyperglycemia, glucose intolerance, hyperinsulinemia, and insulin resistance. One or several among these alterations are also found after starvation, ketogenic diet, and pharmacological treatment with rapamycin or antibody-mediated neutralization of the obesogenic factor ACBP/DBI. Thus, a variety of metabolic interventions that improve metabolic health can induce a transient state of “pseudo-diabetes”.

AB - Type-2 diabetes is characterized by glycosuria, hyperglycemia, glucose intolerance, hyperinsulinemia, and insulin resistance. One or several among these alterations are also found after starvation, ketogenic diet, and pharmacological treatment with rapamycin or antibody-mediated neutralization of the obesogenic factor ACBP/DBI. Thus, a variety of metabolic interventions that improve metabolic health can induce a transient state of “pseudo-diabetes”.

UR - http://www.scopus.com/inward/record.url?scp=85073115384&partnerID=8YFLogxK

U2 - 10.1038/s41419-019-2007-1

DO - 10.1038/s41419-019-2007-1

M3 - Comment/debate

C2 - 31601789

AN - SCOPUS:85073115384

SN - 2041-4889

VL - 10

JO - Cell Death and Disease

JF - Cell Death and Disease

IS - 10

M1 - 765

ER -